Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer. Results of a phase II study in elderly patients or patients with impaired performance status
- K. Abbrederis
- , S. Lorenzen
- , L. Fischer von Weikersthal
- , U. Vehling-Kaiser
- , T. Schuster
- , N. Rothling
- , C. Peschel
- , F. Lordick
- Technical University of Munich
- Klinikum St. Marien Amberg
- Onkologische Schwerpunktpraxis
Research output: Contribution to journal › Review article › peer-review
12
Scopus
citations